Provided by Tiger Fintech (Singapore) Pte. Ltd.

Castle Biosciences, Inc.

20.35
+5.0332.83%
Pre-market: 20.350.00000.00%06:26 EDT
Volume:2.02M
Turnover:41.43M
Market Cap:590.32M
PE:-61.00
High:21.33
Open:19.85
Low:18.68
Close:15.32
Loading ...
Jun 03, 2022

Major Issues Report

8-K - Current report
May 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2022

Major Issues Report

8-K - Current report
May 02, 2022

Major Issues Report

8-K - Current report
Apr 07, 2022

Major Issues Report

8-K - Current report
Apr 04, 2022

Major Issues Report

8-K - Current report
Mar 17, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 14, 2022

Major Issues Report

8-K/A [Amend] - Current report
Jan 10, 2022

Major Issues Report

8-K - Current report
Jan 05, 2022

Major Issues Report

8-K - Current report
Nov 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 12, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 10, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 25, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 25, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities